Title : SAG-UPS attenuates proapoptotic SARM and Noxa to confer survival advantage to early hepatocellular carcinoma.

Pub. Date : 2015

PMID : 27551463






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 SAG-UPS attenuates proapoptotic SARM and Noxa to confer survival advantage to early hepatocellular carcinoma. sagopilone sterile alpha and TIR motif containing 1 Homo sapiens
2 SAG-overexpressing HCC cell lines display reduced SARM and Noxa (but not Bcl-2, Bax and Bcl-xL), suggesting that SARM and Noxa are specific substrates of SAG-dependent ubiquitination. sagopilone sterile alpha and TIR motif containing 1 Homo sapiens
3 SAG-overexpressing HCC cell lines display reduced SARM and Noxa (but not Bcl-2, Bax and Bcl-xL), suggesting that SARM and Noxa are specific substrates of SAG-dependent ubiquitination. sagopilone sterile alpha and TIR motif containing 1 Homo sapiens
4 SAG-overexpressing HCC cell lines display reduced SARM and Noxa (but not Bcl-2, Bax and Bcl-xL), suggesting that SARM and Noxa are specific substrates of SAG-dependent ubiquitination. sagopilone sterile alpha and TIR motif containing 1 Homo sapiens
5 Altogether, early stage-upregulated SAG-UPS exacerbates hepatocarcinogenesis progression, through: (1) ubiquitination-mediated degradation of proapoptotic SARM and Noxa; and (2) production of protumorigenic cytokines that induce a protumorigenic microenvironment, conferring survival advantage to HCC cells. sagopilone sterile alpha and TIR motif containing 1 Homo sapiens